Thoracic neurogenic tumours [Torakal nörojenik tümörler]

dc.contributor.authorÖncel M.
dc.contributor.authorSunam G.S.
dc.contributor.authorKarabagli P.
dc.contributor.authorKarabagli H.
dc.date.accessioned2020-03-26T18:48:08Z
dc.date.available2020-03-26T18:48:08Z
dc.date.issued2013
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractIntrathoracic neurogenic tumours are neoplasms arising from any of the neurogenic elements of the mediastinum. Schwannomas and neurofibromas develop from nerve sheath, ganglioneuromas and neuroblastomas from autonomic ganglions. The aim of in this study we present the clinical and pathological details of these patients and to determine only extending the mediastinum. Materials and methods: We reached retrospective clinical data of 16 patients (10 males and 6 females) with neurogenic tumours of the mediastinum undergoing surgical treatment 2008 to 2012. Age of the patients ranged from 5 to 66 years (mean 46 years). When the patients admitted our clinic to surgery. All patients had detailed history and physical examination, routine chest radiography, electrocardiography and standard laboratory blood tests. For localizations and to define the nature of the tumour whole the patients were performed computed tomographic (CT). Especially when we suspected involvement of intervertebral space and vascular space magnetic resonance imaging. Results: Preoperative symptoms were observed in 13 cases (%81), as follows: back and thoracic pain in 10 (%63), short of breathness in 3 (%19) patient.The preoperative CT showed the tumour as a solid lesion in 16 cases. The tumour was located on the posterior mediastinum in 10 (%63) patients and cases.2 (%13) patients upper mediastinum and 4 (%25) patients from thoracic wall. The histological type of the tumours was in 3 (%19) cases, ganglioneuroma, in 3 (%19) cases benign neurofibroma, in 9 (%56) cases schwannomas. 1 (%6) case originated from malignant peripheral nerve sheet tumour (MPNST). Complete surgical excision was achieved in all patients, with no postoperative mortality. There was no significant intraoperative and postoperative blood loss and no major surgical complications occurred. Conclusions: After the surgical indications may be carefully determined in cases. There is a good result in these tumours. MRI would facilitate therapeutic determination by distinguishing nature, spread and invasion of the neurogenic tumour. Patient with benign neurogenic tumours have a good survival prospect following operations.en_US
dc.identifier.endpage384en_US
dc.identifier.issn1300-1817en_US
dc.identifier.issue2en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage377en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/30074
dc.identifier.volume30en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.relation.ispartofJournal of Neurological Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectNeurogenicen_US
dc.subjectThoracicen_US
dc.subjectTumoursen_US
dc.titleThoracic neurogenic tumours [Torakal nörojenik tümörler]en_US
dc.typeArticleen_US

Dosyalar